Bringing the fundamentals into focus…
Back to Avanos Medical Inc
How Avanos Medical Inc stacks up
AVNS · against 467 other Healthcare companies of similar size
Valuation
33/ 100
Below the middle of the pack.
Ranked #308 of 468 · scores higher than 33% of peers
Bars: peers in each 10-point band of the valuation score35 peers with a valuation score of 30–39, including AVNS · Click a bar to see the companies
Why valuation scores 33?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield, which is weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -6.4% vs peer median 1.5%
- EBITDA yield is not reported, so it is left out of the score.
- Free cash flow yield is close to the peer norm. Free cash flow yield: 0.6% vs peer median 0.0%
Metric by metric
Position: dot = AVNS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AVNS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 459 reported | -6.4% | 1.4% | 25% | 30% | |
| EBITDA yieldHigher is better · 471 reported | Not reported | 4.3% | — | — | 50% |
| Free cash flow yieldHigher is better · 204 reported | 0.6% | -1.6% | 61% | 20% | |
| Book yieldHigher is better · 463 reported | 67.1% | 40.7% | 76% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by valuation score
Top 5 and the companies ranked around AVNS| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 305 | 1.2B CHF (≈$1.4B) | 36 | 34 | |
| 305 | 1.2B USD | 36 | 36 | |
| 305 | 1.9B USD | 36 | 47 | |
| 308 | 642M USD | 33 | 46 | |
| 308 | 1.2B USD | 33 | ||
| 308 | 631M USD | 33 | ||
| 308 | 2.2B USD | 33 | 48 | |
| 308 | 1.8B USD | 33 | ||
| 313 | 6.2B CNY (≈$861M) | 32 | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score